Effects of baclofen and L-AP4 in passive avoidance test in rats after hypoxia-induced amnesia

Pharmacological Reports

Volumn 58, Issue 1, 2006, Pages 91-100

  Car, Halina ^a   Wiśniewska, Róza J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Baclofen; Elevated plus maze; Hypoxia; L AP4; Open field; Passive avoidance; Rat

Indexed keywords

2 AMINO 4 PHOSPHONOBUTYRIC ACID; 4 AMINOBUTYRIC ACID; BACLOFEN; GLUTAMIC ACID; PRESYNAPTIC RECEPTOR;

AMNESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BRAIN HYPOXIA; CONTROLLED STUDY; DRUG POTENTIATION; DRUG RESPONSE; FEMALE; GABAERGIC SYSTEM; HYPOTHERMIA; MAZE TEST; MEMORY CONSOLIDATION; MOTOR PERFORMANCE; NEUROPROTECTION; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE; RAT; RECALL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; TEMPERATURE MEASUREMENT; TRANQUILIZING ACTIVITY;

EID: 33646201101     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Ader R, Weijnen JAWM, Maleman P: Retention of a passive avoidance responses as a function of the intensity and duration of the electric shock. Psychonomic Science, 1972, 26, 125-132.
2. Allweis C, Gibbs ME, Ng KT, Hodge RJ: Effects of hypoxia on memory consolidation: Implications for a multistage model of memory Behav Brain Res, 1984, 11, 117-121.
3. Bai IM, Wang WM, Li TD, Fei Z: Changes in metabotropic glutamate receptor 4 expression and the effects of L-2-amino-4-phosphonobutyrate in a rodent model of diffuse brain injury. Chin J Traumatol, 2004, 7, 233-238.
4. Belan PV, Koslyuk PG: Glutamate-receptor-induced modulation of GABAergic synoptic transmission in the hippocampus. Pfugers Arch, 2002, 444, 26-37.
5. 7] AVP on learning and memory processes in rats with experimental amnesia. Pol J Pharmacol, 1993, 45, 11-12.
6. Car H, Borawska M, Wiśniewski K: The effect of vasopressin analogue [d(CH2)5(1),Tyr(Me)2]AVP on memory process in rats with experimental amnesia. Acta Neurobiol Exp, 1995, 55, 207-211.
7. Car H, Nadlewska A, Oksztel R, Wiśniewski K: AIDA influences behavior in rats pretreated with baclofen. Pol J Pharmacol, 2001, 53, 245-252.
8. Car H, Nadlewska A, Wiśniewski K: 3,5-DHPG influences behavioral effects of baclofen in rats. Pol J Pharmacol, 2000, 52, 247-254.
9. Car H, Oksztel R, Nadlewska A, Wiśniewski K: Baclofen prevents hypoxia-induced consolidation impairment for passive avoidance. Pharmacol Res, 2001, 44, 329-335.
10. Car H, Wiśniewska RJ: Behavioral effects of L-AP4 in rats after hypoxia-induced amnesia. Pol J Pharmacol, 2004, 56, 102.
11. Car H, Wiśniewska RJ, Wiśniewski K: 2R, 4RAPDC influence hypoxia-induced impairment of learning and memory processes in passive avoidance test. Pol J Pharmacol, 2004, 56, 527-537.
12. Car H, Wiśniewski K: Influence of L-AP4 on behavioral effects of baclofen and phaclofen in rats. Pol J Pharmacol, 1999, 51, 275-276.
13. Car H, Wiśniewski K: The effect of baclofen and AP7 on selected behavior in rats. Pharmacol Biochem Behav, 1998, 59, 685-689.
14. B receptor agonists on the mesolimbic dopamine system. Nat Neurosci, 2004, 7, 153-159.
15. De Noble W, Repetti SJ: Vinpocetine: nootropic effects on scopolamine-induced and hypoxia-induced retrieval deficits of a step-through passive avoidance response in rats. Pharmacol Biochem Behav, 1986, 24, 1123-1128.
16. Drew GM, Vaughan CW: Multiple metabotropic glutamate receptor subtypes modulate GABAergic neurotransmission in rat periaqueductal grey neurons in vitro. Neuropharmacology, 2004, 46, 927-934.
17. Dutar P, Nicoll RA: Pre- and postsynaptic GABA-B receptors in the hippocampus have different pharmacological properties. Neuron, 1988, 1, 585-591.
18. Fedosiewicz-Wasiluk M, Hoły ZZ, Wiśniewski K: L-AP4, a potent agonist of group III metabotropic glutamate receptor, decreases central action of angiotensin II. Pol J Pharmacol, 2002, 54, 415-422.
19. B receptors after transient cerebral ischemia in rats. J Neurochem, 1999, 72, 87-94.
20. Giustizieri M, Bernardi G, Mercuri NB, Berretta N: Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta. J Neurophysiol, 2005, 94, 1992-2003.
21. Gutierrez R: The GABAergic phenotype of the "glutamatergic" granule cells of the dentate gyrus. Prog Neurobiol, 2003, 71, 337-358.
22. Harrison NL: On the presynaptic action of baclofen at inhibitory synapses between cultured rat hippocampal neurones. J Physiol, 1990, 422, 433-446.
23. Ho Y, Pawlak CR, Guo L, Schwarting KW: Acute longterm consequences of single MDMA administration in relation to individual anxiety levels in the rat. Behav Brain Res, 2004, 149, 135-144.
24. Holscher C: Inhibitors of metabotropic glutamate receptors produce amnestic effects in chicks. Neuroreport, 1994, 5, 1037-1040.
25. Holscher C, Gigg J, O'Mara SM: Metabotropic glutamate receptor activation and blockade: their role in long-term potentiation, learning and neurotoxicity. Neurosci Biobehav Rev, 1999, 23, 399-410.
26. Holscher Q McGlinchey L, Rowan MJ: L-AP4(L-(+)-2-amino-4-phosphonobutyric acid) induced impairment of spatial learning in the rat is antagonized by MAP4 ((S)-2-amino-2-methyl-4-phosphonobutanoic acid). Behav Brain Res, 1996, 81, 69-79.
27. Iversen L, Mulvihill E, Haldeman B, Diemer NH, Kaiser F, Sheardown MJ, Kristensen P: Changes in metabotropic glutamate receptor mRNA levels following global ischemia: increase of a putative presynaptic subtype (mGluR4) in highly vulnerable brain areas. J Neurochem, 1994, 63, 625-633.
28. Katoh A, Ishibashi C, Shiomi C, Takahara Y, Eigyo M: Ischemia-induced irreversible deficit of memory function in gerbils. Brain Res, 1992, 577, 57-63.
29. Karasawa Y, Araki K, Otomo S: Changes in locomotor activity and passive task performance induced by cerebral ischemia in Mongolian gerbils. Stroke, 1994, 25, 645-650.
30. Klausnitzer J, Kulla A, Manahan-Vaughan D: Role of the group III metabotropic glutamate receptor in LTP, depotentiation and LTD in the dentate gyrus of freely moving rats. Neuropharmacology, 2004, 46, 160-170.
31. Kogo N, Dalezios Y, Capogna M, Ferraguti F, Shigemoto R, Somogyi P: Depression of GABAergic input to identified hippocampal neurons by group III metabotropic glutamate receptors in the rat. Eur J Neurosci, 2004, 19, 2727-2740.
32. Korner J17, Cotman CW: Micromolar L-2-amino-4-phophonobutyric acid selectively inhibits perforant path synapses from lateral entorinal cortex. Brain Res, 1981, 216, 192-197.
33. Matthies H: Pharmacology of learning and memory. Trends Biochem Sci, 1980, 1, 333-337.
34. Myhrer T: Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Rev, 2003, 41, 268-287.
35. Nadlewska A, Car H, Oksztel R, Wiśniewski K: Effect of (S)-3,5-DHPG on learning, exploratory activity and anxiety in rats with experimental hypoxia. Pol J Pharmacol, 2002, 54, 11-18.
36. Nadlewska. A, Car H, Wiśniewska RJ, Wiśniewski K: Influence of AIDA on certain behaviors in rats subjected to experimental hypoxia. Pol J Pharmacol, 2003, 55, 171-180.
37. Nakashima K, Todd MM: Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarisation. Stroke, 1996, 27, 913-918.
38. Pellow S, Chopin P, File SE, Briley M: Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods, 1985, 14, 149-167.
39. Peltekova V, Han G, Soleymanlou N, Hampson DR: Constraints on proper folding of the amino terminal domains of group III metabotropic glutamate receptors. Mol Brain Res, 2000, 76, 180-190.
40. Saransaari P, Oja SS: Characteristics of GABA release modified by glutamate receptors in mouse hippocampal slices. Neurochem Int, 2003, 43, 453-459.
41. Schoepp DD, Jane DE, Monn JA: Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology, 1999, 38, 1431-1476.
42. Schoepp DD: Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther, 2001, 299, 12-20.
43. Sharma AC, Kulkarni SK:. (±) Baclofen sensitive scopolamine-induced short-term memory deficits in mice. Indian J Exp Biol, 1993, 31, 348-352.
44. Shuaib A, Breker-Klassen MM: Inhibitory mechanisms in cerebral ischemia: a brief review. Neurosci Biobehav Rev, 1997, 21, 219-226.
45. Stenfors C, Ross SB: Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine 1A receptors in the mouse brain in vivo. Naunyn Schmiedebergs Arch Pharmacol, 2001, 364, 479-486.
46. Sun MK: Hypoxia, ischemic stroke, and memory deficits: prospects for therapy. IUBMB Life, 1999, 48, 373-378.
47. Sun MK, Xu H, Alkon DL: Pharmacological protection of synaptic function. spatial learning, and memory from transient hypoxia in rats. J Pharmacol Exp Ther, 2002, 300, 408-416;
48. Szapiro G, Barros D, Ardenghi P, Vianna MRM, Choi H, Silva T, Medina JH, Izquierdo I: Facilitation and inhibition of retrieval in two aversive tasks in rats by intrahippocampal infusion of agonists of specific glutamate metabotropic receptor subtypes. Psychopharmacology, 2001, 156, 397-401.
49. Zalewska A, Winnicka MM, Wiśniewski K: Central activity of 2-amino-4-phosphonobutyric acid (AP4). Pol J Pharmacol, 1995, 47, 9-17.
50. Zarrindast MR, Lahiji P, Shafaghi B, Sadegh M: Effects of GABAergic drugs on physostigmine-induced improvement in memory acquisition of passive avoidance learning in mice. Gen Pharmacol, 1998, 31, 81-86.
51. Zarrindast MR, Khodjastehfar E, Oryan S, Torkaman-Boutorabi A: Baclofen-impairment of memory retention in rats: possible interaction with adrenoceptor mechanism(s). Eur J Pharmacol, 2001, 411, 283-288.
52. Zarrindast MR, Bakhsha A, Rostami P, Shafaghi B: Effect of intrahippocampal injection of GABAergic drugs on memory retention of passive avoidance learning in rats. J Psychopharmacol, 2002, 16, 313-319.
53. Zarrindast MR, Shamsi T, Azarmina P, Rostami P, Shafaghi B: GABAergic system and imipramine-induced impairment of memory retention in rats. Eur Neuropsychopharmacol, 2004, 14, 59-64.
54. Zhou F, Hongmin B, Xiang Z, Enyu. L: Changes of MG1uR4 and the effects of its specific agonist L-AP4 in a rodent model of diffuse brain injury. J Clin Neurosci, 2003, 10, 684-688.